PREIX
Price
$156.66
Change
-$0.93 (-0.59%)
Updated
Nov 14 closing price
VTSAX
Price
$143.16
Change
-$0.98 (-0.68%)
Updated
Nov 14 closing price
Ad is loading...

PREIX vs VTSAX

Header iconPREIX vs VTSAX Comparison
Open Charts PREIX vs VTSAXBanner chart's image
T. Rowe Price Equity Index 500
Price$156.66
Change-$0.93 (-0.59%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$143.16
Change-$0.98 (-0.68%)
VolumeN/A
CapitalizationN/A
PREIX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PREIX vs. VTSAX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PREIX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. PREIX (34.8B). VTSAX pays higher dividends than PREIX: VTSAX (1.35) vs PREIX (1.21). PREIX was incepted earlier than VTSAX: PREIX (35 years) vs VTSAX (24 years). PREIX is a more actively managed with annual turnover of: 5.80 vs. VTSAX (2.00). PREIX has a lower initial minimum investment than VTSAX: PREIX (2500) vs VTSAX (3000). PREIX (34.77) and VTSAX (33.39) have marching annual gain over last year. PREIX return over 5 years is better than : 100.91 vs. VTSAX (87.46).
PREIXVTSAXPREIX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence35 years24 years-
Gain YTD26.75424.891107%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets34.8B1.73T2%
Annual Yield % from dividends1.211.3590%
Returns for 1 year34.7733.39104%
Returns for 3 years32.5922.82143%
Returns for 5 years100.9187.46115%
Returns for 10 years221.64194.07114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals